V. Tertov

发表

Lipid accumulation in the subendothelial cells of human aortic intima impairs cell-to-cell contacts: A comparative study in situ and in vitro.

M. Rekhter, V. Tertov, E. Andreeva, 1993, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Multiply modified desialylated low-density lipoproteins: Physicochemical properties

V. V. Kaplun, V. Tertov, A. Orekhov, 2006, Bulletin of Experimental Biology and Medicine.

Multiple modifications of low-density lipoproteins in the blood of patients with atherosclerosis

V. Tertov, A. Orekhov, V. L. Nazarova, 1995, Bulletin of Experimental Biology and Medicine.

Atherogenic Modified LDL in Diabetes

V. Tertov, A. Orekhov, I. Sobenin, 1996, Diabetes.

Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells.

V. Tertov, A. Orekhov, I. Sobenin, 1991, Atherosclerosis.

Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.

V. Tertov, A. Orekhov, I. Sobenin, 1998, Atherosclerosis.

The Effects of Antihypertensive Agents on Atherosclerosis-Related Parameters of Human Aorta Intimal Cells

V. Tertov, A. Orekhov, E. M. Pivovarova, 1998, Cardiology.

Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.

V. Tertov, A. Orekhov, T. Koschinsky, 1993, Atherosclerosis.

Vascular Signal Transduction and Atherosclerosis

V. Tertov, T. Voyno-Yasenetskaya, V. Tkachuk, 1990, Annals of the New York Academy of Sciences.

Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.

V. Tertov, E. Andreeva, A. Orekhov, 1984, Atherosclerosis.

Protein-bound lipids in human low density lipoproteins

V. Tertov, A. Orekhov, V. Kaplun, 1995, Bulletin of Experimental Biology and Medicine.

Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.

V. Tertov, A. Orekhov, I. Sobenin, 1998, Free radical research.

Atherogenic lipoproteins found in the blood of patients with coronary atherosclerosis are desialylated low-density lipoproteins

V. Tertov, A. Orekhov, D. Mukhin, 1990, Bulletin of Experimental Biology and Medicine.

Low-density lipoproteins isolated from blood of coronary patients cause lipid accumulation in human aortic intimal cells

V. Tertov, A. Orekhov, D. Mukhin, 1990, Bulletin of Experimental Biology and Medicine.

Autoantibodies against low-density lipoprotein and atherogenic potential of blood.

V. Tertov, A. Orekhov, A. Kacharava, 1993, Annals of medicine.

Blood Serum Atherogenicity Associated With Coronary Atherosclerosis: Evidence for Nonlipid Factor Providing Atherogenicity of Low‐Density Lipoproteins and an Approach to Its Elimination

V. Tertov, A. Orekhov, V. Smirnov, 1988, Circulation research.

Atherogenic Factors of Blood: Desialylated LDL and Anti-LDL Autoantibodies

V. Tertov, A. Orekhov, 1991 .

Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.

V. Tertov, E. Andreeva, A. Orekhov, 1985, Experimental and molecular pathology.

Interaction of low-density lipoproteins and elastins from the intima and media of human intact and atherosclerotic aorta

V. Tertov, A. Orekhov, I. Suprun, 2000, Bulletin of Experimental Biology and Medicine.

Lipid metabolism in cells of the atherosclerotic human aorta. Experiments in primary culture

V. Tertov, A. Orekhov, V. Kosykh, 1982, Bulletin of Experimental Biology and Medicine.

Characteristics of low‐density lipoprotein subfractions from patients with coronary artery disease

V. Tertov, A. Orekhov, T. Nikkari, 1993, Coronary artery disease.

Effect of components of the extracellular matrix on lipid accumulation in human cells

V. Tertov, A. Orekhov, M. Frid, 1987, Bulletin of Experimental Biology and Medicine.

Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells.

V. Tertov, A. Orekhov, V. Smirnov, 1990, Circulation research.

Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.

V. Tertov, A. Orekhov, V. Smirnov, 1989, Annals of medicine.

Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.

V. Tertov, A. Orekhov, I. Sobenin, 1992, International journal of tissue reactions.

Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.

V. Tertov, A. Orekhov, S. Akopov, 1988, Atherosclerosis.

Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.

V. Tertov, A. Orekhov, V. Smirnov, 1987, The American journal of cardiology.

Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.

V. Tertov, A. Orekhov, V. Smirnov, 1986, Atherosclerosis.

Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.

V. Tertov, A. Orekhov, A. Gotto, 1993, Journal of lipid research.

Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.

V. Tertov, A. Orekhov, I. Novikov, 1991, Advances in experimental medicine and biology.

Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.

V. Tertov, A. Orekhov, I. Sobenin, 1994, International angiology : a journal of the International Union of Angiology.

Oxidation-induced aggregation of LDL increases their uptake by smooth muscle cells from human aorta

V. Tertov, A. Orekhov, O. Panasenko, 2007, Bulletin of Experimental Biology and Medicine.

Effects of radioprotectors on the cAMP and cGMP systems

A. S. Sobolev, V. Tertov, Y. Chirkov, 1984, Radiation and environmental biophysics.

Diagnostic Value of Immune Cholesterol as a Marker for Atherosclerosis

V. Tertov, A. Orekhov, A. Deev, 1995, Journal of cardiovascular risk.

“Regression” of atherosclerosis in cell culture: Effects of stable prostacyclin analogues

V. Tertov, E. Andreeva, A. Orekhov, 1986 .

Degradation of human apolipoprotein B‐100 by apolipoprotein(a)

V. Tertov, T. I. Chulkova, T. Chulkova, 1993, FEBS letters.

Antiatherosclerotic properties of 4-(2,6-dimethylheptyl)-and 4-(2,6,10-trimethylundecyl)benzoic acids and their amides

V. Tertov, A. Orekhov, G. M. Zhdankina, 2006, Pharmaceutical Chemistry Journal.

Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.

V. Tertov, E. Andreeva, A. Orekhov, 1984, The American journal of pathology.

Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.

V. Tertov, A. Orekhov, T. Nikkari, 1992, Laboratory investigation; a journal of technical methods and pathology.

Concentrations of cyclic nucleotides in organ cultures of normal and atherosclerotic human aorta

V. Tertov, A. Orekhov, S. Tabagari, 1989, Bulletin of Experimental Biology and Medicine.

Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.

V. Tertov, A. Orekhov, V. Tkachuk, 1987, Tissue & cell.

Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.

V. Tertov, A. Orekhov, D. Mukhin, 1986, Artificial organs.

Diabetes mellitus and atherosclerosis.

V. Tertov, A. Orekhov, E. S. Slavina, 1987, The New England journal of medicine.

A study of rat liver guanylate cyclase activation by peroxides of fatty acids, carbonyl compounds and biogenic amines.

A. S. Sobolev, V. Tertov, S. Rybalkin, 1983, Biochimica et biophysica acta.

PROSTACYCLIN ANALOGUES AS ANTIATHEROSCLEROTIC DRUGS

V. Tertov, A. Orekhov, VladimirN. Smirnov, 1983, The Lancet.

Antiatherogenic and antiatherosclerotic effects of mushroom extracts revealed in human aortic intima cell culture

V. Tertov, A. Orekhov, V. Tutelyan, 1989 .

Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta.

V. Tertov, A. Orekhov, V. Smirnov, 1982, Biochemical and Biophysical Research Communications - BBRC.

Synthetic analogs of phytanic acid and their effect on human hepatic cholesterol esterase in vitro

V. Tertov, A. G. Nigmatov, G. M. Zhdankina, 2006, Pharmaceutical Chemistry Journal.

Antiatherosclerotic properties of certain components of tea

V. Tertov, A. Orekhov, V. Tutel’yan, 1989, Pharmaceutical Chemistry Journal.

Direct anti-atherosclerosis-related effects of garlic.

V. Tertov, A. Orekhov, I. Sobenin, 1995, Annals of medicine.

Dissociated cells from different layers of adult human aortic wall.

V. Tertov, E. Andreeva, A. Orekhov, 1984, Acta anatomica.

The cGMP system in irradiated animals. Changes in cGMP content and activities of guanylate cyclase and cyclic nucleotide phosphodiesterase.

A. S. Sobolev, V. Tertov, S. Rybalkin, 1984, Acta radiologica. Oncology.

Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta.

V. Tertov, A. Orekhov, V. Koteliansky, 1989, Atherosclerosis.

Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture.

V. Tertov, A. Orekhov, V. Smirnov, 1985, Experimental and molecular pathology (Print).

In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells

V. Tertov, A. Orekhov, 1997, Lipids.

Direct antiatherogenic effect of garlic

V. Tertov, A. Orekhov, I. Sobenin, 1996, Bulletin of Experimental Biology and Medicine.

Effect of plant extracts on trans-sialidase activity in human blood plasma

V. Tertov, A. Orekhov, I. Sobenin, 2007, Bulletin of Experimental Biology and Medicine.

Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.

V. Tertov, A. Orekhov, D. Mukhin, 1991, Atherosclerosis.

Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.

V. Tertov, A. Orekhov, Alexander N. Orekhov, 1997, Experimental and molecular pathology.

Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta.

V. Tertov, E. Andreeva, A. Orekhov, 1986, The American journal of pathology.

Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.

V. Tertov, A. Orekhov, V. Smirnov, 1986, Atherosclerosis.

Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro

V. Tertov, A. Orekhov, I. Sobenin, 2008 .

Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.

V. Tertov, A. Orekhov, N. Bovin, 2001, Atherosclerosis.

Optimization of the assay for sialic acid determination in low density lipoprotein.

V. Tertov, A. Orekhov, I. Sobenin, 1998, Journal of Lipid Research.

Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.

V. Tertov, A. Orekhov, V. Kaplun, 1995, Biochemical and biophysical research communications.

Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.

V. Tertov, A. Orekhov, A. Yaroslavov, 1992, Circulation research.

Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation.

V. Tertov, A. Orekhov, A. Gotto, 1992, Journal of lipid research.

Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.

V. Tertov, A. Orekhov, A. Tonevitsky, 1990, Biochemical and biophysical research communications.

Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.

V. Tertov, A. Orekhov, I. Sobenin, 1989, Biochemical and biophysical research communications.

Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.

V. Tertov, A. Orekhov, I. Mikhailenko, 1989, Biochemical and biophysical research communications.

Desialylation Decreases the Resistance of Apo B-Containing Lipoproteins to Aggregation and Increases Their Atherogenic Potential

V. Tertov, A. Orekhov, O. Panasenko, 2005, Bulletin of Experimental Biology and Medicine.

The content of lipoperoxidation products in normal and atherosclerotic human aorta

V. Tertov, A. Orekhov, I. Mikhailova, 2001, Molecular and Cellular Biochemistry.

In vivo oxidized low desinty lipoprotein: Degree of lipoprotein oxidation does not correlate with its atherogenic properties

V. Tertov, A. Orekhov, V. Kaplun, 1998, Molecular and Cellular Biochemistry.

Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential

V. Tertov, V. Kaplun, A. N. Orekhov, 1997, BioFactors.

Characteristics of low density lipoprotein isolated from circulating immune complexes.

V. Tertov, A. Orekhov, T. Nikkari, 1996, Atherosclerosis.

Lipid composition of multiple modified (desialylated) low-density lipoproteins

V. Tertov, A. Orekhov, I. Sobenin, 1996, Bulletin of Experimental Biology and Medicine.

Interaction between multiply modified (desialylated) low-density lipoproteins isolated from blood of atherosclerotic patients and cell receptors

V. Tertov, I. Sobenin, D. Via, 2006, Bulletin of Experimental Biology and Medicine.

Specificity of human trans-sialidase as probed with gangliosides.

V. Tertov, E. Nikonova, N. Bovin, 2004, Bioorganic & medicinal chemistry letters.

Human Plasma trans - Sialidase Donor and Acceptor Specificity

V. Tertov, A. Orekhov, E. Nikonova, 2002, Biochemistry (Moscow).

Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.

V. Tertov, A. Orekhov, I. Sobenin, 1997, International journal of cardiology.

Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.

V. Tertov, A. Orekhov, I. Sobenin, 2015, Clinical chemistry.

Modified (Desialylated)Low-Density Lipoprotein Measured in Serum by Lectin-Sorbent Assay

V. Tertov, A. Orekhov, I. Sobenin, 1995 .

Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.

V. Tertov, A. Orekhov, V. Smirnov, 1989, Experimental and molecular pathology.

Lipid-laden white blood cells in the circulation of patients with coronary heart disease.

V. Tertov, A. Orekhov, O. Kalenich, 1992, Experimental and molecular pathology.

Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.

V. Tertov, A. Orekhov, I. Sobenin, 1990, Experimental and molecular pathology.

Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.

V. Tertov, A. Orekhov, V. Torchilin, 1987, Experimental and molecular pathology.

Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins.

V. Tertov, A. Orekhov, V. Smirnov, 1984, Biomedica biochimica acta.

Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.

V. Tertov, A. Orekhov, V. Smirnov, 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)].

V. Tertov, A. Orekhov, A. V. Vasil’ev, 1989, Voprosy pitaniia.

Lipoprotein immune complexes as markers of atherosclerosis.

V. Tertov, A. Orekhov, I. Novikov, 1991, International journal of tissue reactions.

Influence of trapidil and trapidil derivatives on the content of cyclic nucleotides in human intima cells cultured from atherosclerotic plaques

V. Tertov, A. Orekhov, I. Heinroth-Hoffmann, 1990 .

Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.

V. Tertov, A. Orekhov, V. Tkachuk, 1988, Journal of cardiovascular pharmacology.

Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells.

V. Tertov, A. Orekhov, V. Smirnov, 1988, Tissue & cell.

Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta.

V. Tertov, A. Orekhov, V. Koteliansky, 1987, Biochimica et biophysica acta.

The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.

V. Tertov, A. Orekhov, A. M. Poverenny, 1992, Clinical immunology and immunopathology.

Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.

V. Tertov, A. Orekhov, V. Smirnov, 1986, Artery.

Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.

M. Rekhter, V. Tertov, E. Andreeva, 1992, Atherosclerosis.

Use of Cell Culture for Optimisation of Direct Antiatherogenic Therapy with Verapamil

V. Tertov, A. Orekhov, I. Sobenin, 2012, Drugs.

Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.

V. Tertov, A. Orekhov, V. Tkachuk, 1990, Herz.

Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta.

V. Tertov, A. Orekhov, V. Tkachuk, 1988, The American journal of cardiology.

Trapidil derivatives as potential antiatherosclerotic drugs.

V. Tertov, A. Orekhov, A. Fahr, 1987, Arzneimittel-Forschung.

ATHEROGENICITY OF BLOOD SERUM FROM PATIENTS WITH CORONARY HEART DISEASE

V. Tertov, A. Orekhov, E. Chazov, 1986, The Lancet.

ARTIFICIAL HDL AS AN ANTI-ATHEROSCLEROTIC DRUG

V. Tertov, A. Orekhov, V. Smirnov, 1984, The Lancet.

Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured from atherosclerotic human aorta.

V. Tertov, A. Orekhov, V. Smirnov, 1986, Artery.

Antiatherosclerotic effects of anipamil, verapamil and other calcium antagonists studied on cell culture

V. Tertov, A. Orekhov, A. Lyakishev, 1990 .

Atherosclerosis-related effects of verapamil, anipamil and other calcium antagonists studied on cell culture

V. Tertov, A. Orekhov, A. Lyakishev, 1990 .

Papaverine abolishes the atherogenic effect of the beta-blocker propranolol

M. Rekhter, V. Tertov, E. Andreeva, 1992, Bulletin of Experimental Biology and Medicine.

Atherogenic effect of the beta-blocker propranolol exhibited on the de-endothelized rabbit aorta

M. Rekhter, V. Tertov, E. Andreeva, 1991, Bulletin of Experimental Biology and Medicine.

Antiatherosclerotic and atherogenic properties of certain natural compounds andβ;-adrenoblockers

V. Tertov, A. Orekhov, V. Tutel’yan, 1989, Pharmaceutical Chemistry Journal.

Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.

V. Tertov, A. Orekhov, I. Sobenin, 1995, Experimental and molecular pathology.

Polyunsaturated phosphatidylcholine micelle-induced decrease of atherogenicity of the serumin vitro

V. Tertov, A. Orekhov, T. Torkhovskaya, 1995, Bulletin of Experimental Biology and Medicine.

Isolation of desialylated low-density lipoproteins from blood of coronary heart disease patients by affinity chromatography

V. Tertov, A. Orekhov, I. Sobenin, 1990, Bulletin of Experimental Biology and Medicine.

Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.

V. Tertov, A. Orekhov, V. Smirnov, 1990, Atherosclerosis.

Lipoprotein Aggregation

V. Tertov, A. Orekhov, A. Yaroslavov, 2005 .

Three Types of Naturally Occurring Modified Lipoproteins Induce Intracellular Lipid Accumulation in Human Aortic Intimal Cells — The Role of Lipoprotein Aggregation

V. Tertov, A. Orekhov, M. Jauhiainen, 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Postradiation disturbances in the cyclic AMP system of lymphocytes of the mouse spleen and thymus

A. S. Sobolev, V. Tertov, A. Orekhov, 1978, Bulletin of experimental biology and medicine.

[Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver].

A. S. Sobolev, V. Tertov, A. Orekhov, 1977, Doklady Akademii nauk SSSR.

Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome.

V. Tertov, S. Skarlatos, H. Kruth, 1992, Journal of Biological Chemistry.

Immunocytochemical study of the localization of scavenger receptor in human aortic smooth-muscle cells

V. Tertov, E. Andreeva, A. Orekhov, 1995, Bulletin of Experimental Biology and Medicine.

Lowering the intracellular lipid concentration in the atherosclerotic human aorta by compounds raising the intracellular cAMP level

V. Tertov, A. Orekhov, V. Smirnov, 1984, Bulletin of Experimental Biology and Medicine.

Effect of eicosanoids on cholesterol accumulation and subendothelial cell proliferation in the human aorta

V. Tertov, A. Orekhov, S. Akopov, 2004, Bulletin of Experimental Biology and Medicine.

Search for lipoxygenase inhibitors and study of their pharmacological activity

V. Tertov, S. Akopov, E. Gabrielyan, 1989, Pharmaceutical Chemistry Journal.